SCHEMBL3243443

SCHEMBL3243443

Fc1ccc(C2=CCCCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
ACMSD Q8TDX5 2/20 0.46
PTGS2 P35354 1/20 0.40
MAPK14 Q16539 1/20 0.39
HDAC1 Q13547 3/20 0.39
HDAC2 Q92769 3/20 0.39
HDAC3 O15379 2/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
PAX8 Q06710 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
FFAR2 O15552 1/20 0.36
MAPK1 P28482 1/20 0.36
PSMB5 P28074 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1257261 0.98 CASP3 (0.46) CASP3SENP8SENP7SENP6ACMSD
SCHEMBL362370 0.93 ACMSD (0.44) CASP3SENP8SENP7SENP6ACMSD
SCHEMBL10793933 0.88 ACMSD (0.53) CASP3SENP8SENP7SENP6ACMSD
SCHEMBL1257281 0.82 CASP3 (0.47) CASP3SENP8SENP7SENP6ACMSD
SCHEMBL13221420 0.80 MAPK14 (0.40) CASP3SENP8SENP7SENP6PTGS2
SCHEMBL17070223 0.80 CASP3 (0.46) CASP3SENP8SENP7SENP6ACMSD
SCHEMBL1257285 0.79 ACMSD (0.49) CASP3SENP8SENP7SENP6ACMSD
SCHEMBL16978437 0.78 ACMSD (0.45) CASP3SENP8SENP7SENP6ACMSD
SCHEMBL11034153 0.78 CHRNB4 (0.49) CASP3SENP8SENP7SENP6ACMSD
SCHEMBL188943 0.77 MEN1 (0.55) ACMSDPTGS2HDAC1HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689291-B1 MIXTURE OF POLAR COMPOUNDS HAVING POSITIVE DIELECTRIC ANISOTROPY, COMPRISING AT LEAST ONE FLUOROPHENYLCYCLOHEXENE DERIVATIVE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2004-02-10 US claimed
EP-0014840-B1 FLUORPHENYL-TRANS-CYCLOHEXANES, PROCESS FOR THEIR PREPARATION, LIQUID CRYSTALLINE DIELECTRICS CONTAINING THEM AND ELECTROOPTICAL DISPLAYING MEANS MERCK PATENT GmbH (DE) 1982-01-06 EP claimed
EP-0014840-A1 Fluorphenyl-trans-cyclohexanes, process for their preparation, liquid crystalline dielectrics containing them and electrooptical displaying means MERCK PATENT GmbH (DE) 1980-09-03 EP claimed
JP-6306361-A None JP disclosed
WO-2024182597-A1 VISIBLE LIGHT DRIVEN CO2 VALORIZATION The Board of Regents for the Oklahoma Agricultural and Mechanical Colleges (US) 2024-09-06 WO disclosed
US-9458155-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC (US) 2016-10-04 US disclosed
US-9458155-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC (US) 2016-10-04 US disclosed
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2015-02-19 US disclosed
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2015-02-19 US disclosed
US-8906925-B2 Pyrido[4,3-B]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
US-8906925-B2 Pyrido[4,3-B]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
EP-1780193-B1 LIQUID CRYSTAL MATERIAL, METHOD FOR PRODUCING LIQUID CRYSTAL MATERIAL AND LIQUID CRYSTAL DEVICE JAPAN SCIENCE & TECH AGENCY (JP) 2010-05-19 EP disclosed
WO-2010051501-A1 PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. (US) 2010-05-06 WO disclosed
JP-2009138204-A LIQUID CRYSTAL MEDIUM MERCK PATENT GMBH 2009-06-25 JP disclosed
JP-2005113152-A LIQUID-CRYSTAL MEDIUM MERCK PATENT GMBH 2005-04-28 JP disclosed
US-6689291-B1 MIXTURE OF POLAR COMPOUNDS HAVING POSITIVE DIELECTRIC ANISOTROPY, COMPRISING AT LEAST ONE FLUOROPHENYLCYCLOHEXENE DERIVATIVE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2004-02-10 US disclosed
US-6689291-B1 MIXTURE OF POLAR COMPOUNDS HAVING POSITIVE DIELECTRIC ANISOTROPY, COMPRISING AT LEAST ONE FLUOROPHENYLCYCLOHEXENE DERIVATIVE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2004-02-10 US disclosed
JP-H06306361-A LIQUID CRYSTAL MEDIUM MERCK PATENT GMBH 1994-11-01 JP disclosed
EP-0014840-B1 FLUORPHENYL-TRANS-CYCLOHEXANES, PROCESS FOR THEIR PREPARATION, LIQUID CRYSTALLINE DIELECTRICS CONTAINING THEM AND ELECTROOPTICAL DISPLAYING MEANS MERCK PATENT GmbH (DE) 1982-01-06 EP disclosed
EP-0014840-A1 Fluorphenyl-trans-cyclohexanes, process for their preparation, liquid crystalline dielectrics containing them and electrooptical displaying means MERCK PATENT GmbH (DE) 1980-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A CASP3 345/4885SENP8 4709/4885SENP7 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.